Indication
Cytomegaloviral Infection
6 clinical trials
5 products
Clinical trial
Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer PatientsStatus: Recruiting, Estimated PCD: 2025-01-31
Clinical trial
Most Closely HLA Matched Allogeneic CMV Specific Cytotoxic T-Lymphocytes (CTL) to Treat CMV Infection After Hemapoietic Stem Cell Transplantation (HSCT)Status: Active (not recruiting), Estimated PCD: 2025-08-31
Clinical trial
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell TransplantStatus: Active (not recruiting), Estimated PCD: 2018-03-04
Product
CMVpp65-A*0201Clinical trial
A Phase 1/2 Clinical Study to Evaluate the Optimal Dose and the Protective Effect of CMV-MVA Triplex Vaccine in Pediatric Patients Receiving an Allogeneic Hematopoietic Stem Cell TransplantStatus: Recruiting, Estimated PCD: 2024-11-11
Clinical trial
A Phase 1b Safety and Immunogenicity Study of Cytomegalovirus (CMV) Directed Type 1 Polarized Dendritic Cell Vaccination (αDC1) After Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Hematologic MalignanciesStatus: Withdrawn, Estimated PCD: 2024-11-16
Clinical trial
A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate the Protective Function of a CMV-MVA Triplex Vaccine in Recipients of an Allogeneic Hematopoietic Stem Cell TransplantStatus: Active (not recruiting), Estimated PCD: 2018-01-25